Literature DB >> 8596388

Protease inhibitors fly through FDA.

A A Barnett.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8596388     DOI： 10.1016/s0140-6736(96)91219-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Community health advocacy.

Authors:  Sana Loue
Journal:  J Epidemiol Community Health       Date:  2006-06       Impact factor: 3.710

2.  Timing of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infection.

Authors:  Amy S Sturt; Meira S Halpern; Barbara Sullivan; Yvonne A Maldonado
Journal:  Pediatr Infect Dis J       Date:  2012-01       Impact factor: 2.129

3.  Temporal trends in mucocutaneous findings among human immunodeficiency virus 1-infected children in a population-based cohort.

Authors:  Amy S Sturt; Andrew Anglemyer; David R Berk; Yvonne A Maldonado
Journal:  Pediatr Dermatol       Date:  2012-11-07       Impact factor: 1.588
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.